High-dose Chemotherapy and Autologous Stem Cell Rescue in Patients with High-risk Stage 3 Neuroblastoma: 10-Year Experience at a Single Center

High-dose chemotherapy and autologous stem cell rescue (HDCT/ASCR) was applied to improve the prognosis of patients with high-risk stage 3 neuroblastoma. From January 1997 to December 2006, 28 patients were newly diagnosed as stage 3 neuroblastoma. Nine of 11 patients with N-myc amplification and 5...

Descripción completa

Detalles Bibliográficos
Autores principales: Suh, Jung Min, Yoo, Keon Hee, Sung, Ki Woong, Kim, Ju Youn, Cho, Eun Joo, Koo, Hong Hoe, Lee, Suk Koo, Kim, Jhingook, Lim, Do Hoon, Suh, Yeon Lim, Kim, Dae Won
Formato: Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2009
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2719186/
https://www.ncbi.nlm.nih.gov/pubmed/19654949
http://dx.doi.org/10.3346/jkms.2009.24.4.660

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2719186/
https://www.ncbi.nlm.nih.gov/pubmed/19654949
http://dx.doi.org/10.3346/jkms.2009.24.4.660

Ejemplares similares